Treatment of progressive multifocal Leukoencephalopathy associated with idiopathic lymphocytopenia with Nivolumab

J Neurol Sci. 2021 Aug 15:427:117503. doi: 10.1016/j.jns.2021.117503. Epub 2021 May 20.
No abstract available

Keywords: Activation; Cerebellar syndrom.; Immune checkpoint-inhibitor; Immunomodulation; JC-virus; Neuroimmunology; T cell.

Publication types

  • Letter

MeSH terms

  • Humans
  • JC Virus*
  • Leukoencephalopathy, Progressive Multifocal* / diagnostic imaging
  • Leukoencephalopathy, Progressive Multifocal* / drug therapy
  • Leukopenia*
  • Lymphopenia* / chemically induced
  • Lymphopenia* / complications
  • Lymphopenia* / drug therapy
  • Nivolumab / adverse effects

Substances

  • Nivolumab